CHICAGO, May 27 (Reuters) – The U.S. Food and Drug Administration said it approved Medtronic Inc’s (MDT.N) artificial cervical disc, a titanium and polyurethane device that fits between adjacent neck bones to replace a diseased or bulging cervical disc that often causes neck pain.
The FDA cleared the device, called Bryan, on May 12, 2009, the agency said on its website on Wednesday.
The disc is designed to stabilize the spine. Unlike the conventional fusion procedure, the device allows motion.
The patient should have failed at least six weeks of conservative therapy before receiving the device, the FDA announcement said.
Medtronic was not immediately available to comment.
Shares of Medtronic were up 1 percent, or 31 cents, at $33.87 in midday New York Stock Exchange trade.